ArticleCancer discovery2015

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.

Elena Sotillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.